Most of the CML patients express b2a2 or b3a2 of BCR-ABL mRNA encoding for p210 Bcr-Abl tyrosine kinase [18]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.